Too Simple to Notice, Too Important to Ignore: Why Methods Projects Matter—and How to Build One That Shines

🧠 The Hidden Weak Links That Power Science

Ask yourself:

“What’s something we all do in clinical research—but never truly question?”

These aren’t grand controversies or breakthrough techniques. They’re the quiet defaults—the “routine” choices that shape how we analyze data, design trials, and infer truth. But here’s the paradox: their very normality hides their risk.

Think:

Are most published clinical prediction models really well-calibrated on new populations? [6]
When is modified intention-to-treat analysis actually more misleading than helpful? [10]
Do trialists who claim “real-world relevance” really pass the PRECIS-2 smell test? [12]
Are DAGs superior to multivariable adjustment in low-sample etiologic studies—or just fancier? [2]

These are method defaults, not sacred truths. And that makes them fertile ground for PhD-level discovery.

🔍 Step 1: Pick a Quietly Ubiquitous Method

Don’t chase “cool.” Chase unexamined. Look for:

Method	Simple Starting Point	Deep Potential
mITT vs ITT	Simulate dropout and compliance patterns	Reveal bias profiles under real-world deviations [10]
DAG adjustment	Compare DAG-based vs classical regression in small samples	Explore causal inference fragility [2]
Risk model calibration	Re-validate top CPMs on external datasets	Chart generalizability failures [6]
Trial pragmatism	Blind-score PRECIS-2 on self-labeled “pragmatic” trials	Audit the claim vs design mismatch [12]

These aren’t just pet peeves. They’re methods stories waiting for rigor.

⚗️ Step 2: Choose Simulation or Reanalysis

Two tools = PhD power:

Simulation: Build your own DAG, vary one core input (e.g., noncompliance %, mediator misclassification), and track metrics like bias, coverage, or net benefit.
Reanalysis: Use open-access datasets (e.g., MIMIC, PhysioNet, ClinicalTrials.gov) and rerun published analyses with modified assumptions.

🎯 Pro Tip: The best simulation studies keep one dimension constant, so causal effects are clear. Then tweak only one thing—like the exclusion rule or misclassification.

📊 Step 3: Use Outcome Metrics That Show Real Insight

Forget p-values. Show what matters:

Bias = difference from true value.
Coverage = % of intervals capturing truth.
Calibration slope/intercept = how well CPMs generalize [6].
Net Benefit = model’s clinical utility.
Inflation = size of treatment effect distortion under bias [10].

Think impact, not just significance.

✨ Step 4: Build a Thesis-Worthy Methods Question

Here are ready-to-run ideas—steal, remix, or ask me to co-design one with you:

Area	Question
RCT analysis	How often do mITT and CACE yield divergent conclusions in non-inferiority RCTs? [10][11]
Causal inference	How much does DAG misclassification of colliders skew estimates in small n? [2]
CPM evaluation	What % of high-impact CPMs are miscalibrated in validation datasets? [6]
Trial design	Are “pragmatic” trials really scoring ≥4 on PRECIS-2 domains? [12]
Ethics	How inconsistent are informed consent forms across high-income countries? [7]

✅ Summary Takeaways

Great methods projects hide in routines we take for granted.
Focus on defaults: mITT, DAGs, CPM calibration, trial “pragmatism.”
Simulations and reanalysis offer high insight at low cost.
Use metrics like bias, coverage, calibration, and net benefit.
Start with: What do we all do in clinical research—but never question?